Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Naropin (ropivacaine HCl) Injection,Rx AstraZeneca L.P. NDA 20-533/S-002 11/2/00 Naropin Indication:for the production of local or regional anesthesia for surgery and for acute pain management. Naropin (ropivacaine HCl) Injection, AstraZeneca, Labeling Revision | Naropin (ropivacaine HCl) Injection, Abraxis BioScience, Labeling Revision | Ropivacaine Hydrochloride Injection, Navinta LLC, Tentative Approval | Ropivacaine Hydrochloride Injection, Navinta, LLC, Tentative Approval | Naropin (ropivacaine hydrochloride monohydrate) Injection, APP Pharmaceuticals, Labeling Revision | Ropivacaine Hydrochloride Injection, Sagent Pharmaceuticals, Inc., Tentative Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com